Envision this possible future clinical scenario: a breast cancer patient and her physicians are deciding on the best possible ...

US-based Iambic Therapeutics has concluded the dose escalation phase in its multi-centre Phase I/Ib trial of a ...

Envision this possible future clinical scenario: a breast cancer patient and her physicians are deciding on the best possible ...

US-based Avenzo Therapeutics has commenced the open-label Phase I/II trial of its cyclin-dependent kinase 4 (CDK4) selective ...

Results from the Phase III VERITAC-2 trial demonstrated that vepdegestrant reduced the risk of disease progression or death ...

Recent results from the NRG-NSABP B-51/RTOG 1304 clinical study showed that the addition of regional nodal irradiation (RNI) ...

Recent results from the NRG-NSABP B-51/RTOG 1304 clinical study showed that the addition of regional nodal irradiation (RNI) does not decrease the ...

I would like to thank the Press for publishing the annual voting records of deputies. The 2022 records brought back a particularly difficult period in my life and I wish to provide context for my four ...

ACCURATE determination of HER-2 status in breast cancer is essential for guiding targeted therapy and improving clinical ...

Fengting Yan, MD, PhD, discusses unmet needs in breast cancer care and issues for specific subgroups of patients.

The April 10, 2026 release for “Ready or Not 2” positions the film as a precursor to the highly saturated summer blockbuster ...

At the 2025 ASCO (American Society of Clinical Oncology) Annual Meeting, Dr. Armenian presented findings from the session ...